Neuroectodermal Tumors, Primitive, Peripheral
Recent clinical, regulatory, research and industry developments relating to this disease.
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Bone Neoplasms1
- Neuroectodermal Tumors, Primitive, Peripheral1
- Osteosarcoma1
- Sarcoma, Ewing1
Leading journals1
- Pediatric blood & cancer1
Leading researchers8
- Binitie O1
- Davis J1
- DuBois SG1
- Grohar P1
- Janeway KA1
- Krailo M1
- Reed DR1
- Rubin E1
Affiliations (unnormalised)6
- Children's Hospital of Orange County1
- Children's Hospital of Philadelphia Research Institute1
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center1
- Department of Pathology and Laboratory Medicine1
- Keck School of Medicine1
- Moffitt Cancer Center1
Reference
Authoritative identity, definition & identifiers.
A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.